igf-1 lr3 gh gut prevention The GH/IGF-1 axis in obesity: pathophysiology and therapeutic considerations IGF-1 LR3 in Aesthetic and

For weight loss and metabolism Semaglutide (GLP-1 agonist) - #1 for menopausal weight: Why it's best: Directly addresses insulin resistance common after 40 Reduces appetite dramatically 15-20% body weight loss typical Works when diet/exercise alone fail FDA-approved for weight loss Dosing for women 40+: Start: 0.25mg weekly Titrate slowly to 1-2.4mg over 16-20 weeks Weekly injection subcutaneous 3-6+ months for best results Timeline: Month 1: Appetite reduction begins Month 2-3: 10-15 lbs lost Month 4-6: 20-30 lbs lost (if needed) Maintain: Lower dose ongoing Use our semaglutide dosage calculator and see semaglutide vs tirzepatide comparison

Allameh, A., Niayesh-Mehr, R., Aliarab, A., Sebastiani, G., & Pantopoulos, K

Yi et al., 2025)

Protocol structure: 3-month progressive dose escalation, 5 days on/2 days off, before bed

NACET is well-tolerated by most healthy adults

NACs safety record spans over 50 years of clinical use 16 , first as a medical intervention and now as a supplement